Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Update

Global X HealthTech ETF (NASDAQ:HEAL) was the recipient of a significant decrease in short interest in January. As of January 30th, there was short interest totaling 6,028 shares, a decrease of 76.2% from the January 15th total of 25,312 shares. Approximately 0.5% of the company’s stock are sold short. Based on an average daily volume of 11,893 shares, the short-interest ratio is currently 0.5 days. Based on an average daily volume of 11,893 shares, the short-interest ratio is currently 0.5 days. Approximately 0.5% of the company’s stock are sold short.

Global X HealthTech ETF Price Performance

NASDAQ HEAL opened at $25.24 on Friday. Global X HealthTech ETF has a fifty-two week low of $24.48 and a fifty-two week high of $35.73. The stock’s 50-day moving average is $29.54 and its two-hundred day moving average is $30.89. The firm has a market cap of $33.57 million, a P/E ratio of 42.80 and a beta of 1.13.

Global X HealthTech ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, January 7th. Investors of record on Tuesday, December 30th were paid a $0.0718 dividend. The ex-dividend date of this dividend was Tuesday, December 30th.

Hedge Funds Weigh In On Global X HealthTech ETF

Several hedge funds and other institutional investors have recently added to or reduced their stakes in HEAL. Daiwa Securities Group Inc. bought a new position in shares of Global X HealthTech ETF in the third quarter valued at approximately $11,239,000. Flow Traders U.S. LLC acquired a new position in Global X HealthTech ETF in the 3rd quarter valued at $368,000. Raymond James Financial Inc. bought a new position in Global X HealthTech ETF in the 3rd quarter worth $274,000. WT Wealth Management lifted its position in Global X HealthTech ETF by 10.1% during the 4th quarter. WT Wealth Management now owns 88,171 shares of the company’s stock worth $2,576,000 after acquiring an additional 8,066 shares during the last quarter. Finally, Citadel Advisors LLC acquired a new position in Global X HealthTech ETF during the 3rd quarter worth $216,000.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.